Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT-Reference-Cited by-同舟云学术

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

Published:2017-12-18 Issue:3 Volume:53 Page:255-263
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

van Gorkom Gwendolyn, ,van Gelder Michel,Eikema Dirk-Jan,Blok Henric-Jan,van Lint M. T.,Koc Yener,Ciceri Fabio,Beelen Dietrich,Chevallier Patrice,Selleslag Dominik,Blaise Didier^ORCID,Foá Roberto,Corradini Paolo,Castagna Luca^ORCID,Moreno Carol,Solano Carlos,Müller Lutz Peter,Tischer Johanna,Hilgendorf Inken,Hallek Michael,Bittenbring Jörg,Theobald Matthias,Schetelig Johannes,Kröger Nicolaus,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-017-0023-2.pdf

Reference30 articles.

1. O’Brien SM, Furman RR, Coutre SE, Flinn IW, Burger J, Blum K, et al. Five-year experience with single-agent ibrutinib in patients with previously untreated and relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia. Blood 2016;128:233.

2. Mauro FR, Tedeschi A, Piciocchi A, Motta M, Iannella E, Farina L, et al. Outcome of patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and/or 17p deletion/TP53 mutations treated with Ibrutinib according to a Named Patient Program (NPP) in Italy: preliminary analysis of a real life retrospective study. Blood 2016;128:2038.

3. Sharma RG, Call TG, Habermann TM, Ding W, Leis JF, Schwager S, et al. Outcomes of chronic lymphocytic leukemia patients with Richter syndrome. Blood 2013;122:4179.

4. Mato AR, Nabhan C, Barr PM, Ujjani CS, Hill BT, Lamanna N, et al. Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience. Blood 2016;128:2199–205.

5. Mato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, et al. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: Results from a multi-center study of 683 patients. Annal Oncolo. 2017;28:1050–1056.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation;Bone Marrow Transplantation;2024-06-14

2. Hematopoietic Cell Transplantation and Other Cellular Therapies for Chronic Lymphocytic Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia;Cancer Consult;2023-11-18

4. The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review;Frontiers in Oncology;2023-01-18

5. Stem Cell Transplant for B Cell Non-Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023